Cargando…
Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases
BACKGROUND: Metastatic spread of tumor cells remains a serious problem in cancer treatment. Gene-directed enzyme/prodrug therapy mediated by tumor-homing genetically engineered mesenchymal stromal cells (MSC) represents a promising therapeutic modality for elimination of disseminated cells. Efficacy...
Autores principales: | Matuskova, Miroslava, Kozovska, Zuzana, Toro, Lenka, Durinikova, Erika, Tyciakova, Silvia, Cierna, Zuzana, Bohovic, Roman, Kucerova, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431639/ https://www.ncbi.nlm.nih.gov/pubmed/25884597 http://dx.doi.org/10.1186/s13046-015-0149-2 |
Ejemplares similares
-
ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells
por: Durinikova, Erika, et al.
Publicado: (2018) -
Erratum to: Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
por: Skolekova, Svetlana, et al.
Publicado: (2016) -
Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells
por: Kucerova, Lucia, et al.
Publicado: (2013) -
Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation
por: Kucerova, Lucia, et al.
Publicado: (2016) -
Potential Effects of Chrysin on MDA-MB-231 Cells
por: Hong, Teh Ban, et al.
Publicado: (2010)